Latest filing published 02 Oct 2026 for Stoke Therapeutics, Inc., €24k. Read the official filing
All filings by Barry Ticho on record concern Stoke Therapeutics, Inc., in the capacity of senior executive. Over a trading history stretching from 13 July 2021 to 1 October 2026, the count stands at 49 filings.
Sales make up the whole of the open-market record (31 sales, €3.3M). Other entries cover 18 option exercises. So far in 2026, the count stands at no purchases and 11 sales.
Most recently, on 2 October 2026, the filings show an open-market sale worth €24k in Stoke Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 49 declarations